Article info

Download PDFPDF
CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

Authors

  • S. Memarzadeh Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UCLA School of Medicine, University of California-Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • S. B. Lee Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UCLA School of Medicine, University of California-Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • J. S. Berek Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UCLA School of Medicine, University of California-Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • R. Farias-Eisner Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UCLA School of Medicine, University of California-Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  1. Address correspondence or reprint requests to: Robin P. Farias-Eisner, MD, PhD, Associate Professor, UCLA School of Medicine, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 10833 Le Conte Avenue, Los Angeles, CA 90095–1740. Email: rfeisner{at}mednet.ucla.edu.

Citation

Memarzadeh S, Lee SB, Berek JS, et al
CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

Publication history

  • First published February 1, 2003.
Online issue publication 
February 01, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.